The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of concomitant medication use on treatment outcomes in patients with RCC treated with immune checkpoint inhibitors.
 
Ahmet Yildirim
No Relationships to Disclose
 
Mengting Wei
No Relationships to Disclose
 
Yuan Liu
No Relationships to Disclose
 
Yujin Choi
No Relationships to Disclose
 
Lauren Suh
No Relationships to Disclose
 
Dylan Martini
No Relationships to Disclose
 
Caitlin Hartman
No Relationships to Disclose
 
Greta McClintock
No Relationships to Disclose
 
Tony Zhuang
No Relationships to Disclose
 
Wayne Harris
No Relationships to Disclose
 
Jordan Ciuro
No Relationships to Disclose
 
Jacob Berchuck
Stock and Other Ownership Interests - Cityblock Health (I); Genome Medical; Musculo; Oncotect; Precede Bio; TracerDx
Honoraria - Guardant Health
Consulting or Advisory Role - Genome Medical; Guardant Health; Musculo; Oncotect; Precede Bio; TracerDx
Speakers' Bureau - Guardant Health
Research Funding - Guardant Health (Inst); Precede Bio (Inst)
Patents, Royalties, Other Intellectual Property - Institutional patent filed on methods for detecting prostate cancer resistance using cell-free DNA
Travel, Accommodations, Expenses - Guardant Health
 
Jacqueline Brown
Consulting or Advisory Role - Exelixis; Xencor
Research Funding - Hookipa Pharma (Inst); Medicenna (Inst); Merck (Inst); Surface Oncology (Inst); Xencor (Inst)
 
Bassel Nazha
Honoraria - Intellisphere, LLC (Onclive)
Consulting or Advisory Role - Cardinal Health; Exelixis; IntrinsiQ
 
Bradley Carthon
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Gilead Sciences; Immunomedics
Research Funding - Alkermes (Inst); MedImmune (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Omer Kucuk
No Relationships to Disclose
 
Viraj Master
Honoraria - Ethicon; Exelixis
Research Funding - Exelixis; Merck (Inst)
 
Mehmet Bilen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; SeaGen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Merck (Inst); Nektar (Inst); NiKang Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)